Your session is about to expire
← Back to Search
Behavioral Intervention
Meditation for Improving Quality of Life in Glaucoma Patients
N/A
Waitlist Available
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged 65-75
Patients diagnosed with mild glaucoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 3, week 6, week 12
Awards & highlights
Study Summary
This trial seeks to improve Quality of Life for visually impaired seniors during the COVID-19 pandemic with a meditation technique.
Who is the study for?
This trial is for individuals aged 65-75 with mild glaucoma, who can use a computer, sit comfortably for over half an hour, and have good hearing. They should be in overall good health without significant mental disorders or severe depression. Participants must understand English and provide informed consent.Check my eligibility
What is being tested?
The study tests if online meditation can improve life quality and mental health in glaucoma patients. It compares the effects of meditation to usual care using questionnaires on health, depression, anxiety, and sleep at multiple points during the study.See study design
What are the potential side effects?
Meditation is generally safe but may include temporary discomfort like restlessness or difficulty concentrating. Rarely it could trigger emotional distress especially if there are underlying mental health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 65 and 75 years old.
Select...
I have been diagnosed with mild glaucoma.
Select...
I can use a computer by myself for online meditation sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1, week 3, week 6, week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 3, week 6, week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The 12-item short form survey
Secondary outcome measures
Anxiety
Depression
Sleep quality
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Meditation to Remove Stress and Create A Proper System in MindExperimental Treatment1 Intervention
The study intervention will be administered to participants randomized to the intervention arm. The meditation intervention will be delivered virtually via the hospital-approved Microsoft Teams platform. Participants will be taught an evidence-based meditation technique which includes two online sessions (60 minutes/day) with a trained, experienced, and certified teacher of Prasanna Wellness, a non-profit service organization. Participants will learn how to respond to experiences that arise in meditation, will discuss what enhances or detracts from effective meditation, and review methods for meditating at home. The participants in the intervention arm will complete 60-minute follow-up sessions with the Prasanna Wellness staff which will include 33 minutes of guided meditation practice, and then a discussion of participants' experiences with meditation during the week, additional observations, and a review of relevant knowledge to support their home practice.
Group II: Usual CareActive Control1 Intervention
Participants will continue with their usual care.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,328 Total Patients Enrolled
5 Trials studying Glaucoma
407 Patients Enrolled for Glaucoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have participated in a study that used similar methods or techniques.I am between 65 and 75 years old.I can sit comfortably for over 30 minutes, hear well, and am in good health.I have been diagnosed with mild glaucoma.I have not had a stroke, heart attack, or severe illness in the last 6 months.You do not have any major mental health disorders.I can use a computer by myself for online meditation sessions.I am unable to understand or sign the consent form.I have been diagnosed with severe depression.I have been diagnosed with a serious mental disorder like bipolar or schizophrenia.You have used drugs or alcohol excessively in the last 3 months.I cannot complete questionnaires due to irreversible vision loss.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Meditation to Remove Stress and Create A Proper System in Mind
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for participation in this clinical experiment?
"Clinicaltrials.gov indicates that this trial is not recruiting participants currently; the study was initially posted on May 1st 2023, and last edited on January 20th 2023. Nevertheless, there are 2673 other medical studies actively enrolling patients in need of assistance."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger